Copernicus Capital Management as of March 31, 2020
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 14 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | 15.1 | $13M | 53k | 237.95 | |
| Bristol Myers Squibb (BMY) | 11.9 | $9.9M | 177k | 55.74 | |
| Cigna Corp (CI) | 11.7 | $9.7M | 55k | 177.18 | |
| BioMarin Pharmaceutical (BMRN) | 10.6 | $8.7M | 103k | 84.50 | |
| CVS Caremark Corporation (CVS) | 9.3 | $7.7M | 130k | 59.33 | |
| McKesson Corporation (MCK) | 8.3 | $6.9M | 51k | 135.25 | |
| Biogen Idec (BIIB) | 6.9 | $5.7M | 18k | 316.39 | |
| Thermo Fisher Scientific (TMO) | 6.5 | $5.4M | 19k | 283.61 | |
| Fate Therapeutics (FATE) | 4.3 | $3.6M | 161k | 22.21 | |
| Zoetis Inc Cl A (ZTS) | 4.3 | $3.5M | 30k | 117.68 | |
| Centene Corporation (CNC) | 3.4 | $2.8M | 47k | 59.40 | |
| Tandem Diabetes Care (TNDM) | 3.3 | $2.7M | 43k | 64.36 | |
| Arena Pharmaceuticals | 2.3 | $1.9M | 45k | 42.00 | |
| Shockwave Med | 2.0 | $1.7M | 50k | 33.18 |
